1. Home
  2. RIG vs TMDX Comparison

RIG vs TMDX Comparison

Compare RIG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transocean Ltd (Switzerland)

RIG

Transocean Ltd (Switzerland)

HOLD

Current Price

$4.26

Market Cap

4.3B

Sector

Energy

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$137.22

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIG
TMDX
Founded
1926
1998
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.2B
IPO Year
1993
2019

Fundamental Metrics

Financial Performance
Metric
RIG
TMDX
Price
$4.26
$137.22
Analyst Decision
Hold
Buy
Analyst Count
8
8
Target Price
$4.50
$144.25
AVG Volume (30 Days)
30.0M
659.2K
Earning Date
02-17-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.70
EPS
N/A
2.54
Revenue
$3,874,000,000.00
$566,354,000.00
Revenue This Year
$12.54
$38.81
Revenue Next Year
N/A
$20.49
P/E Ratio
N/A
$54.13
Revenue Growth
16.93
41.20
52 Week Low
$1.97
$55.00
52 Week High
$4.56
$156.00

Technical Indicators

Market Signals
Indicator
RIG
TMDX
Relative Strength Index (RSI) 57.25 61.87
Support Level $4.15 $120.17
Resistance Level $4.46 $133.29
Average True Range (ATR) 0.14 4.87
MACD 0.02 1.34
Stochastic Oscillator 66.10 90.00

Price Performance

Historical Comparison
RIG
TMDX

About RIG Transocean Ltd (Switzerland)

Transocean Ltd. is an international provider of offshore contract drilling services for oil and gas wells. Its segment involves contracting mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: